Maynard Um
-
-
-
-
-
-
-
AbCellera (ABCL) Tops Q2 EPS by 2c
-
-
-
-
-
-
-
AbCellera (ABCL) Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers
-
-
-
-
-
-
-
Benchmark Downgrades AbCellera Biologics (ABCL) to Hold
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

